Drug application
LIVOSTIN (LEVOCABASTINE HYDROCHLORIDE)
Drugs@FDA NDA 020219 · NOVARTIS
Key facts
| Drug name | LIVOSTIN |
|---|---|
| Active ingredients | LEVOCABASTINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 020219 |
| Company | NOVARTIS |
| Dosage forms | SUSPENSION/DROPS, OPHTHALMIC |
| Strength | EQ 0.05% BASE |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Nov 10, 1993 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.